An antimalarial drug helped reduce deaths in hospitalized patients infected with Covid-19, according to a large retrospective study published Thursday.
Coronavirus patients treated with the drug hydroxychloroquine within the first two days of admission were more likely to survive than patients who received other treatment, according to the study, which was published online by the International Journal of Infectious Diseases.
Real Life. Real News. Real Voices
Help us tell more of the stories that matterBecome a founding member
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe